C282H343N13O38 — CID 159792628
bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-[3-(4-methylpiperazin-1-yl)propoxy]chromen-2-one);bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-morpholin-4-ylpropoxy)chromen-2-one);bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-piperazin-1-ylpropoxy)chromen-2-one);8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-piperidin-1-ylpropoxy)chromen-2-one;bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-pyrrolidin-1-ylpropoxy)chromen-2-one) (PubChem CID 159792628) has the molecular formula C282H343N13O38 and a molecular weight of 4522.90 g/mol. Its IUPAC name is bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-[3-(4-methylpiperazin-1-yl)propoxy]chromen-2-one);bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-morpholin-4-ylpropoxy)chromen-2-one);bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-piperazin-1-ylpropoxy)chromen-2-one);8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-piperidin-1-ylpropoxy)chromen-2-one;bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-pyrrolidin-1-ylpropoxy)chromen-2-one).
| Compound Name | bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-[3-(4-methylpiperazin-1-yl)propoxy]chromen-2-one);bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-morpholin-4-ylpropoxy)chromen-2-one);bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-piperazin-1-ylpropoxy)chromen-2-one);8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-piperidin-1-ylpropoxy)chromen-2-one;bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-pyrrolidin-1-ylpropoxy)chromen-2-one) |
|---|---|
| PubChem CID | 159792628 |
| Molecular Formula | C282H343N13O38 |
| Molecular Weight | 4522.90 g/mol |
| Exact Mass | 4519.53 |
| IUPAC Name | bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-[3-(4-methylpiperazin-1-yl)propoxy]chromen-2-one);bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-morpholin-4-ylpropoxy)chromen-2-one);bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-piperazin-1-ylpropoxy)chromen-2-one);8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-piperidin-1-ylpropoxy)chromen-2-one;bis(8-methyl-3-[2-[4-methyl-3-(3-methylbut-2-enyl)phenyl]-2-oxoethyl]-7-(3-pyrrolidin-1-ylpropoxy)chromen-2-one) |
| SMILES | CC(C)=CCc1cc(C(=O)Cc2cc3ccc(OCCCN4CCCC4)c(C)c3oc2=O)ccc1C.CC(C)=CCc1cc(C(=O)Cc2cc3ccc(OCCCN4CCCC4)c(C)c3oc2=O)ccc1C.CC(C)=CCc1cc(C(=O)Cc2cc3ccc(OCCCN4CCCCC4)c(C)c3oc2=O)ccc1C.CC(C)=CCc1cc(C(=O)Cc2cc3ccc(OCCCN4CCN(C)CC4)c(C)c3oc2=O)ccc1C.CC(C)=CCc1cc(C(=O)Cc2cc3ccc(OCCCN4CCN(C)CC4)c(C)c3oc2=O)ccc1C.CC(C)=CCc1cc(C(=O)Cc2cc3ccc(OCCCN4CCNCC4)c(C)c3oc2=O)ccc1C.CC(C)=CCc1cc(C(=O)Cc2cc3ccc(OCCCN4CCNCC4)c(C)c3oc2=O)ccc1C.CC(C)=CCc1cc(C(=O)Cc2cc3ccc(OCCCN4CCOCC4)c(C)c3oc2=O)ccc1C.CC(C)=CCc1cc(C(=O)Cc2cc3ccc(OCCCN4CCOCC4)c(C)c3oc2=O)ccc1C |
| InChI | InChI=1S/2C32H40N2O4.C32H39NO4.2C31H38N2O4.2C31H37NO5.2C31H37NO4/c2*1-22(2)7-9-25-19-26(10-8-23(25)3)29(35)21-28-20-27-11-12-30(24(4)31(27)38-32(28)36)37-18-6-13-34-16-14-33(5)15-17-34;1-22(2)9-11-25-19-26(12-10-23(25)3)29(34)21-28-20-27-13-14-30(24(4)31(27)37-32(28)35)36-18-8-17-33-15-6-5-7-16-33;2*1-21(2)6-8-24-18-25(9-7-22(24)3)28(34)20-27-19-26-10-11-29(23(4)30(26)37-31(27)35)36-17-5-14-33-15-12-32-13-16-33;2*1-21(2)6-8-24-18-25(9-7-22(24)3)28(33)20-27-19-26-10-11-29(23(4)30(26)37-31(27)34)36-15-5-12-32-13-16-35-17-14-32;2*1-21(2)8-10-24-18-25(11-9-22(24)3)28(33)20-27-19-26-12-13-29(23(4)30(26)36-31(27)34)35-17-7-16-32-14-5-6-15-32/h2*7-8,10-12,19-20H,6,9,13-18,21H2,1-5H3;9-10,12-14,19-20H,5-8,11,15-18,21H2,1-4H3;2*6-7,9-11,18-19,32H,5,8,12-17,20H2,1-4H3;2*6-7,9-11,18-19H,5,8,12-17,20H2,1-4H3;2*8-9,11-13,18-19H,5-7,10,14-17,20H2,1-4H3 |
| InChIKey | NITHXUZUPHJGPH-UHFFFAOYSA-N |
| XLogP | 50.66 |
| TPSA | 586.75 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 51 |
| Rotatable Bonds | 90 |
| Heavy Atoms | 333 |
| Complexity | — |
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 4522.90 |
| LogP ≤ 5 | 50.66 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 51 |